Steve Seedhouse
Stock Analyst at Cantor Fitzgerald
(3.38)
# 962
Out of 5,131 analysts
14
Total ratings
69.23%
Success rate
2.34%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Steve Seedhouse
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WVE Wave Life Sciences | Maintains: Overweight | $34 → $41 | $12.68 | +223.34% | 2 | Feb 5, 2026 | |
| KRRO Korro Bio | Upgrades: Overweight | $21 | $11.17 | +88.00% | 2 | Jan 28, 2026 | |
| APLS Apellis Pharmaceuticals | Maintains: Overweight | $39 → $35 | $21.70 | +61.29% | 2 | Jan 13, 2026 | |
| BLTE Belite Bio | Assumes: Overweight | $154 | $175.70 | -12.35% | 1 | Nov 24, 2025 | |
| XNCR Xencor | Maintains: Overweight | $40 → $42 | $11.60 | +262.07% | 2 | Nov 6, 2025 | |
| INVA Innoviva | Maintains: Overweight | $29 → $31 | $22.72 | +36.44% | 2 | Nov 6, 2025 | |
| CAMP Camp4 Therapeutics | Initiates: Overweight | $7 | $3.85 | +81.82% | 1 | Oct 2, 2025 | |
| TVRD Tvardi Therapeutics | Initiates: Overweight | $52 | $3.72 | +1,297.85% | 1 | Jul 11, 2025 | |
| HROW Harrow | Initiates: Overweight | $76 | $47.69 | +59.36% | 1 | Jul 11, 2025 |
Wave Life Sciences
Feb 5, 2026
Maintains: Overweight
Price Target: $34 → $41
Current: $12.68
Upside: +223.34%
Korro Bio
Jan 28, 2026
Upgrades: Overweight
Price Target: $21
Current: $11.17
Upside: +88.00%
Apellis Pharmaceuticals
Jan 13, 2026
Maintains: Overweight
Price Target: $39 → $35
Current: $21.70
Upside: +61.29%
Belite Bio
Nov 24, 2025
Assumes: Overweight
Price Target: $154
Current: $175.70
Upside: -12.35%
Xencor
Nov 6, 2025
Maintains: Overweight
Price Target: $40 → $42
Current: $11.60
Upside: +262.07%
Innoviva
Nov 6, 2025
Maintains: Overweight
Price Target: $29 → $31
Current: $22.72
Upside: +36.44%
Camp4 Therapeutics
Oct 2, 2025
Initiates: Overweight
Price Target: $7
Current: $3.85
Upside: +81.82%
Tvardi Therapeutics
Jul 11, 2025
Initiates: Overweight
Price Target: $52
Current: $3.72
Upside: +1,297.85%
Harrow
Jul 11, 2025
Initiates: Overweight
Price Target: $76
Current: $47.69
Upside: +59.36%